WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.66 Cr | ₹1.94 Cr | ₹-21 Cr | ₹13 Cr | ₹7.34 Cr |
What is the latest Net Cash Inflow / Outflow ratio of WANBURY ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.66 Cr |
| Mar2024 | ₹1.94 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹7.34 Cr |
How is Net Cash Inflow / Outflow of WANBURY Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.66 Cr | -66.07 | |
| Mar2024 | ₹1.94 Cr | Positive | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹13 Cr | 70.64 | |
| Mar2021 | ₹7.34 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹817.2 Cr | 1.2% | -2.1% | -14.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 1.2% |
-2.1% |
-14.3% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses